The invention relates to compounds represented by the general formula (I): and pharmaceutically acceptable salts thereof, wherein n is an integer from 1 to 5; p is an integer from 0 to 4; R1 is selected from the group consisting of a hydroxyl group, an alkoxy group, a thiol group, and a thioether group; R2 and R3 are independently a methylene group or a nucleophile, with the proviso that at least one of R2 and R3 is a nucleophile group; Z is an oxygen (O) atom or sulfur (S) atom; T is hydrogen or an optionally substituted aliphatic group; with the proviso that when n = 2, R1 is not -OCH3 on the carbon-3 position of the phenyl group and R1 is not -OH on the carbon-4 position of the phenyl group.
该发明涉及由通式(I)表示的化合物及其药学上可接受的盐,其中n是1到5的整数;p是0到4的整数;R1从羟基、烷氧基、
硫醇基和
硫醚基组成的群体中选取;R2和R3独立地是亚甲基基团或亲核试剂,但至少其中之一是亲核试剂基团;Z是氧(O)原子或
硫(S)原子;T是氢或可选择取代的脂肪族基团;但当n=2时,R1不是苯基的碳-3位置上的-甲氧基,且R1不是苯基的碳-4位置上的-羟基。